olaparib,abiraterone
astrazeneca,merck
['propel', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'lynparza']
and now we know the likely reason why the fda delayed lynparza's dec 2022 pdufa date by 3 months #gu23 
Journalist at Evaluate Vantage. Interested in: oncology, immunology. Not interested in: what stock you bought today.